Dr. Gary Fong Awarded Industry Grant for Initiative with Underserved Patient Populations
Melinta Theraputics has awarded an Industry Grant to Dr. Gary Fong for his proposal, “Identifying the Need and Potential Role for a Novel Long-Acting Antifungal in a Diverse, Underserved Population“ , totaling $19,836. Dr. Fong will be working alongside his Co-Principal Investigator Dr. Scott Filler, Professor of Medicine at David Geffen School of Medicine at
